intravit - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

ozurdex

abbvie limited - dexamethasone 700ug - intraocular implant - 700 mcg - active: dexamethasone 700ug excipient: polyglactin (poly (d, l-lactide-co-glycolide), 50:50 plga acid) polyglactin - ozurdex® is indicated for the treatment of macular oedema due to retinal vein occlusion (rvo).

European Union - English - EMA (European Medicines Agency)

beovu

novartis europharm limited - brolucizumab - wet macular degeneration - ophthalmologicals - beovu is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (amd).

New Zealand - English - Medsafe (Medicines Safety Authority)

vabysmo

roche products (nz) ltd - faricimab 120 mg/ml - solution for injection - 120 mg/ml - active: faricimab 120 mg/ml excipient: acetic acid histidine methionine polysorbate 20 sodium chloride sucrose water for injection - vabysmo is indicated for the treatment of: · neovascular (wet) age-related macular degeneration (namd)

Philippines - English - FDA (Food And Drug Administration)

unbranded 700mcg

zuellig pharma corporation; distributor: zuellig pharma corporation - dexamethasone - sustained release sterile rod-shaped implant for ophthalmic intravitreal injection - 700mcg